Research programme: monoclonal antibody therapeutics - Kymab

Drug Profile

Research programme: monoclonal antibody therapeutics - Kymab

Alternative Names: Anti-OPG Antibody; KY 1003; KY 1006; KY 1007; KY 1009; KY 1015; KY 1016; KY 1017; KY 1020; KY 1021; KY 1031; KY 1034; KY 1040; KY 1041; KY 1043; KY 1044; KY 1047; KY 1050; KY 1055; KY 7001; KY 7002; KY 7003; KY 7004; KY 7005; KY 7006; Ky3

Latest Information Update: 25 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kymab
  • Class Monoclonal antibodies
  • Mechanism of Action Immunomodulators; Immunostimulants; Inducible T-cell co-stimulator protein antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cancer; Inflammatory bowel diseases; Pulmonary hypertension
  • Research Haematological disorders; Systemic lupus erythematosus
  • Discontinued Cardiovascular disorders; Dyslipidaemias; Fibrosis; Graft-versus-host disease; Infections; Pain

Most Recent Events

  • 21 Apr 2018 Preclinical trials in Cancer in United Kingdom (Parenteral)
  • 21 Apr 2018 Pharmacodynamics data from preclinical studies in Cancer presented at the 109th Annual Meeting of the American Association for Cancer Research (AACR-2018)
  • 11 Nov 2017 Preclinical trials in Pulmonary hypertension in United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top